Tumor Evasion of the Immune System

Tumor evasion of the immune system includes cells that operate their own growth and develop various strategies to escape from immune surveillance. Discover the latest research on tumor evasion of the immune system here.

September 24, 2020

A lncRNA prognostic signature associated with immune infiltration and tumour mutation burden in breast cancer

Journal of Cellular and Molecular Medicine
Zijian LiuLiling Zhang
September 26, 2020
Case Report
Open Access

Giant solitary fibrous tumor of the pelvis: A case report and review of literature

International Journal of Surgery Case Reports
Gerardo PalmieriPatrizio Capelli
September 26, 2020
Review

The science and medicine of human immunology

Science
Bali Pulendran, Mark M Davis
September 25, 2020
Preprint

Macrophage-derived insulin/IGF antagonist ImpL2 regulates systemic metabolism for mounting an effective acute immune response in Drosophila

BioRxiv : the Preprint Server for Biology
G. KrejcovaTomas Dolezal
September 24, 2020
Open Access

The Pancreatic Microbiome is Associated with Carcinogenesis and Worse Prognosis in Males and Smokers

Cancers
Jaideep ChakladarWeg M Ongkeko
September 26, 2020
Open Access

Thymic Engraftment by in vitro -Derived Progenitor T Cells in Young and Aged Mice

Frontiers in Immunology
Jastaranpreet SinghJuan Carlos Zúñiga-Pflücker
September 24, 2020
Review
Open Access

Immunosenescence: the role of age in multiple sclerosis

Neurología : publicación oficial de la Sociedad Española de Neurología
A Ostolaza IbáñezT Ayuso Blanco
September 26, 2020
Review
Open Access

Expression and Role of the G Protein-Coupled Estrogen Receptor (GPR30/GPER) in the Development and Immune Response in Female Reproductive Cancers

Frontiers in Endocrinology
Christian David Hernández-SilvaAna Laura Pereira-Suárez
September 25, 2020

Manipulating immune system using nanoparticles for an effective cancer treatment: Combination of targeted therapy and checkpoint blockage miRNA

Journal of Controlled Release : Official Journal of the Controlled Release Society
Hanh Thuy NguyenJong Oh Kim
September 25, 2020

Interferon Regulatory Factor 7 Attenuates Chronic Gammaherpesvirus Infection

Journal of Virology
K E JohnsonV L Tarakanova
September 26, 2020
Review
Open Access

Key Players in the Mutant p53 Team: Small Molecules, Gene Editing, Immunotherapy

Frontiers in Oncology
Vitaly ChasovEmil Bulatov
September 26, 2020
Review
Open Access

Antigen Recognition by MR1-Reactive T Cells; MAIT Cells, Metabolites, and Remaining Mysteries

Frontiers in Immunology
Alexandra J CorbettZhenjun Chen
September 26, 2020
Open Access

Long Non-Coding RNA Paternally Expressed Imprinted Gene 10 (PEG10) Elevates Diffuse Large B-Cell Lymphoma Progression by Regulating Kinesin Family Member 2A (KIF2A) via Targeting MiR-101-3p

Medical Science Monitor : International Medical Journal of Experimental and Clinical Research
Jin ZhaoJianjun Jiang
September 24, 2020
Review
Open Access

Progress of immune checkpoint LAG-3 in immunotherapy

Oncology Letters
Chanchan ShanJian Zhang
September 25, 2020
Preprint

CHARTS: A web application for characterizing and comparing tumor subpopulations in publicly available single-cell RNA-seq datasets

BioRxiv : the Preprint Server for Biology
M. N. BernsteinRon Stewart
September 26, 2020
Open Access

Tumor-Infiltrating Lymphocytes (TILs) and Risk of a Second Breast Event After a Ductal Carcinoma in situ

Frontiers in Oncology
Alberto FarolfiAndrea Rocca
September 25, 2020
Review
Open Access

Targeting tumor-associated macrophages in the tumor microenvironment

Oncology Letters
Kaiwen ZhouMuying Ying

Sign up to follow this feed and discover related papers.

Related Feeds

CAR-T cells

Chimeric antigen receptor (CAR) T cells are cells that are genetically engineered to recognize and target specific proteins. The ability of these cells to recognize cancer antigens and eliminate tumor cells have transformed cancer immunotherapy approaches. Here is the latest research on CAR-T cells.

Cancer Immunotherapy

Cancer immunotherapy is an important field of research that is looking at controlling cancer and tumor growth by activating the individuals own immune system. Recent studies have utilized chimeric antigen receptor t-cell therapy, immune checkpoint inhibitors and neoantigen vaccines. Discover the latest research on cancer immunotherapy here.

Exosomes & Tumor Environment

Several studies have reported the role of exosomes as important mediators of angiogenesis, metastasis, and immune modulation. Exosomes also have the potential to be used as biomarkers for clinical predictions. Here is the latest research on exosomes and the tumor microenvironment.

Graft Rejection

Graft rejection occurs when the donor's grafted tissue is rejected by the recipient's immune system, destroying the transplanted tissue. Discover the latest research on graft rejection here.

Graft vs Host Disease

Graft-versus-host disease (GVHD) is a major cause of morbidity and mortality after allogeneic haematopoietic cell transplantation from unrelated donors. Here is the latest research.


Immune Therapies In Cancer

Immunotherapy in cancer is used to help the immune system fight against invading cancer cells. It is used to slow the progression of the disease and prevent metastasis while enhancing the immune response. There are different types, including monoclonal antibodies and checkpoint inhibitors. Here is the latest research on immune therapies in cancer.

Immuno-Oncology

Immuno-oncology (or cancer immunotherapy) is the artificial stimulation of the immune system to treat cancer, improving on the immune system's natural ability to fight cancer. It exploits the fact that cancer cells often have tumor antigens, molecules on their surface that can be detected by the antibody proteins of the immune system, binding to them. The tumor antigens are often proteins or other macromolecules. Normal antibodies bind to external pathogens, but the modified immunotherapy antibodies bind to the tumor antigens marking and identifying the cancer cells for the immune system to inhibit or kill. Discover the latest research on immuno-oncology here.

Immunosuppression

Immunosuppression trends for solid organ transplantation have undergone a perceptible shift over the past decade. Discover the latest research on immunosuppression here.

Metastatic Malignancy Treatments

Treatment of metastatic cancers depends on the type of cancer and the severity of the disease. The regime often includes medications such as chemotherapy or hormone therapy, but may also include immunotherapy, radiation therapy, surgery or a combination. Discover the latest research on metastatic cancer treatments here.

Tumor Vaccines

Tumor vaccines offer the potential for preventing cancer in high-risk individuals, preventing disease relapse after diagnosis and initial therapy, and shifting the balance of the host-tumor interaction to mitigate the progression of advanced cancers. Discover the latest research on tumor vaccines here.

© 2020 Meta ULC. All rights reserved
/feed-previews/tumor-evasion-of-the-immune-system/be958748-445f-4674-8e24-b70acda3dba8